Tag: Respiratory syncytial virus
News
Repertoire and Bristol Myers Squibb to develop tolerizing vaccines for autoimmune diseases
Repertoire Immune Medicines, a biotechnology company pioneering the discovery and development of programmable T cell targeted immune medicines, has entered a multi-year strategic collaboration...
Regeneron and Mammoth collaborate on CRISPR-based gene editing for multiple diseases
Regeneron Pharmaceuticals and Mammoth Biosciences have formed a collaboration to research, develop and commercialize in vivo CRISPR-based gene editing therapies for multiple tissues and...
X4 Pharmaceuticals gains FDA approval for WHIM syndrome drug XOLREMDI
The U.S. Food and Drug Administration (FDA) has approved X4 Pharmaceuticals' XOLREMDI (mavorixafor) capsules for use in patients 12 years of age and older...
